Science Current Events | Science News | Brightsurf.com
 

Extra-aggressive form of idiopathic pulmonary fibrosis identified

May 30, 2007
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disorder from which most patients die within 5 years after diagnosis. The disease is characterized by the insidious onset of dyspnea or cough and usually evolves slowly.

Now, Selman and coworkers present in an article published in the online, open-access journal PLoS ONE on Wednesday 30th May, strong evidence indicating that a subset of IPF patients has a short duration of symptoms before diagnosis and display an accelerated clinical course to end-stage disease. The authors postulate that these "rapid progressor" patients, predominantly smoking males, represent a distinct clinical phenotype compared with the usual "slow progressors" patients.

"These findings highlight the variability in the progression and outcome of IPF, and may explain, in part, the difficulty in obtaining significant and reproducible results in studies of therapeutic interventions in patients with IPF," said Dr Selman, who is the Director of Research at the National Institute of Respiratory Research in Mexico City and the lead author on this publication. "They also suggest that physicians should pay more attention to the time of onset of symptoms, and to look for other signs that allow the identification of these rapid progressor patients".

In this study the authors performed global gene expression analysis and other molecular studies in a subset of patients and identified a number of genes that were differentially expressed in both groups, suggesting that rapid progressors are biologically distinct from slow progressors.

"While preliminary, these results may allow investigators to identify biomarkers of disease progression," said Dr King, who is the Chief of Medicine at San Francisco General Hospital and an internationally renowned expert in research and management of pulmonary fibrosis.

The senior author on this paper, Dr Naftali Kaminski, who is the Director of the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh, added that this research highlighted the need to collect as much information on patients with IPF as possible. "We are only now starting to really understand the disease and characterize it," he said, "therefore, it is critical for patients with the disease to be seen in centers that are actively involved in IPF research."

Better identification and understanding of these differences may provide insights into the pathogenesis of IPF and assist in the development of therapeutic interventions for this devastating lung disease.

Public Library of Science


Related Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles


Fat a culprit in fibrotic lung damage
Pulmonary fibrosis has no cure. It's caused by scarring that seems to feed on itself, with the tougher, less elastic tissue replacing the ever moving and stretching lung, making it increasingly difficult for patients to breathe.

Jackson Laboratory researchers discover lung regeneration mechanism
A research team led by Jackson Laboratory Professors Frank McKeon, Ph.D., and Wa Xian, Ph.D., reports on the role of certain lung stem cells in regenerating lungs damaged by disease.

Reversing the effects of pulmonary fibrosis
Yale University researchers are studying a potential new treatment that reverses the effects of pulmonary fibrosis, a respiratory disease in which scars develop in the lungs and severely hamper breathing.

Idiopathic pulmonary fibrosis cases linked with asbestos exposure
A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study.

Longer telomeres linked to risk of brain cancer
New genomic research led by UC San Francisco (UCSF) scientists reveals that two common gene variants that lead to longer telomeres, the caps on chromosome ends thought by many scientists to confer health by protecting cells from aging, also significantly increase the risk of developing the deadly brain cancers known as gliomas.

Toxins in the environment might make you older than your years
Why are some 75-year-olds downright spry while others can barely get around? Part of the explanation, say researchers writing in the Cell Press journal Trends in Molecular Medicine on May 28, is differences from one person to the next in exposure to harmful substances in the environment, chemicals such as benzene, cigarette smoke, and even stress.

X-ray dark-field radiography provides detailed imaging of lung diseases
Scientists at the Helmholtz Zentrum München (HMGU) working in cooperation with the Ludwig-Maximilians-Universität Hospital and the Technische Universität München (TUM) have for the first time tested X-ray dark-field radiography on a living organism to diagnose lung disease.

Studies published in NEJM identify promising drug therapies for fatal lung disease
Researchers in separate clinical trials found two drugs slow the progression of idiopathic pulmonary fibrosis, a fatal lung disease with no effective treatment or cure, and for which there is currently no therapy approved by the Food and Drug Administration.

Protein molecule may improve survival in deadly lung disease
Researchers at the University of Illinois at Chicago College of Medicine have discovered a protein molecule that seems to slow the progression of pulmonary fibrosis, a progressive lung disease that is often fatal three to five years after diagnosis.

Patients with rare lung disease face agonizing treatment dilemma
Doctors who treat patients with a severe and progressive respiratory disease called lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision.
More Pulmonary Fibrosis Current Events and Pulmonary Fibrosis News Articles

Pulmonary Fibrosis: Coping With a Terminal Disease

Pulmonary Fibrosis: Coping With a Terminal Disease
by Lifestyle Design Solutions


Pulmonary Fibrosis: Coping With a Terminal Disease by Robert Post

What do you do when you learn you have Pulmonary Fibrosis, a terminal disease for which there is presently no cure? The author relates his personal experience and explains how he has learned to cope with the disease, products and methods he uses for maintaining health and combating progression of the disease and explains how you can, too.

A linked resources section gives advice on finding and using support groups and Pulmonary Rehabilitation programs. Products and sources are identified that the author has found to be beneficial or vital for health maintenance.

This publication contains frank material that some may find disturbing to read but the author feels the patient and their caregiver...

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis

Breathing Should Never Be Hard Work: One Man's Journey with Idiopathic Pulmonary Fibrosis
by Robert Davidson (Author)


Robert Davidson was diagnosed with Idiopathic Pulmonary Fibrosis in October 2007 after having difficulties with the fitness test necessary to retain senior level soccer referee status. Rather than give in to the disease and die, he decided to fight and live as normal a life as possible, borrowing from Winston Churchill, the mantra "Never surrender". He and his wife, Heather, believe it was this attitude that led to him "winning" a double lung transplant January 30, 2010, just weeks before he would have died from the disease. This book is about his journey with that life threatening disease. Although it "steals away the sufferer's breath" Robert travelled to China (finding 12,800 feet up the Himalayas too high) and to the highlands of Scotland for his wife's 60th birthday celebration. ...

Journey of the CareGiver: Battling Pulmonary Fibrosis

Journey of the CareGiver: Battling Pulmonary Fibrosis
by MS, Lois Moody RN (Author)


The latest edition of this book (Surviving Caregiving) is available for the same price at: www.amazon.com/Surviving-Caregiving-Challenges-Lois-Moody/dp/1501029878/ref=sr_1_4?ie=UTF8&qid=1410298234&sr=8-4&keywords=surviving+caregiving

Improving Fibrosis in 30 Days

Improving Fibrosis in 30 Days
by Naturally Healthy Publications


Improving Fibrosis in 30 Days includes a rehabilitation plan to improve your pulmonary fibrosis symptoms and to attain long term health.

Improving Lung Health in 30 Days: Pulmonary Rehabilitation Plan for COPD, Emphysema, Fibrosis, Bronchiectasis and More

Improving Lung Health in 30 Days: Pulmonary Rehabilitation Plan for COPD, Emphysema, Fibrosis, Bronchiectasis and More
by Robert Redfern (Author)


Improving Lung Health in 30 Days includes a rehabilitation plan to recover lung health and improve pulmonary conditions such as bronchitis, bronchiectasis, COPD, cystic fibrosis and emphysema amongst others.

The Official Patient's Sourcebook on Idiopathic Pulmonary Fibrosis

The Official Patient's Sourcebook on Idiopathic Pulmonary Fibrosis
by James N. Parker (Author)


This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to idiopathic pulmonary fibrosis (also alveolocapillary block; cryptogenic fibrosing alveolitis; diffuse fibrosing alveolitis; fibrosing alveolitis; Hamman-Rich syndrome; idiopathic diffuse interstitial pulmonary fibrosis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various...

Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide (Respiratory Medicine)

Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide (Respiratory Medicine)
by Keith C. Meyer (Editor), Steven D. Nathan (Editor)


Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide delivers a concise review of our current understanding of disease pathogenesis and provides current evidence in the medical literature regarding its diagnosis and management. Each chapter includes key points and a summary aiming to update clinicians about various issues concerning the diagnosis and management of IPF. In addition to outlining the current state of knowledge, each chapter also provides a summary of ongoing research and identifies the needs for future research in the field. Idiopathic Pulmonary Fibrosis: A Comprehensive Clinical Guide is an important new text that provides its readers with a better understanding of the pathobiology and natural history of IPF as it continues to evolve.

Pulmonary Pathophysiology: The Essentials (PULMONARY PATHOPHYSIOLOGY (WEST))

Pulmonary Pathophysiology: The Essentials (PULMONARY PATHOPHYSIOLOGY (WEST))
by John B. West MD PhD (Author)


This companion monograph to West's Respiratory Physiology covers normal respiratory function and focuses on the function of the diseased lung. Pulmonary Pathophysiology: The Essentials offers a concise overview of the diseased states of the lung, emphasizing structure and function. The Eighth Edition is updated to include new information on asthma therapies, new radiographs and micrographs, extended sections on infections and cancer, more thorough explanations for review questions, and a new summary appendix of equations with sample calculations.

Idiopathic Pulmonary Fibrosis (Lung Biology in Health and Disease)

Idiopathic Pulmonary Fibrosis (Lung Biology in Health and Disease)
by Joseph P. Lynch (Editor)


A discussion of the epidemiology, clinical features, and differential diagnoses of idiopathic pulmonary fibrosis (IPF). Key topics include the role of polymorphonuclear leukocytes in the pathogenesis of pulmonary fibrosis, and current treatment options, including medical therapy and lung transplantation.

Symptom to Diagnosis An Evidence Based Guide, Third Edition (Lange Medical Books)

Symptom to Diagnosis An Evidence Based Guide, Third Edition (Lange Medical Books)
by Scott Stern (Author), Adam Cifu (Author), Diane Altkorn (Author)


Learn the diagnostic process in internal medicine with this engaging, case-based approach Symptom to Diagnosis teaches you an evidence-based, step-by-step process for evaluating, diagnosing, and treating patients based on their clinical complaints. By applying this process, you will be able to recognize specific diseases and prescribe the most effective therapy. Each chapter addresses one common complaint and begins with a case and guidance on how to organize the differential diagnosis. As the case progresses, clinical reasoning is explained in detail. The differential diagnosis for that particular case is summarized in tables that highlight the clinical clues and important tests for the leading diagnostic hypothesis and alternative diagnostic hypotheses. As the chapter progresses, the...

© 2014 BrightSurf.com